COVID-19, monkeypox, and the need for vaccines in low- and middle-income countries
DOI:
https://doi.org/10.17533/udea.hm.v13n1a01Palabras clave:
Covid19Resumen
Over the last two years, the world has faced the challenge and devastation that the Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS-CoV-2) and its Coronavirus Disease 2019 (COVID-19) pandemic has imposed,[1] especially to low- and middle-income countries (LMIC) including those from Latin America, as is the case of Colombia.
Descargas
Citas
[1] Rabaan AA, Al-Ahmed SH, Sah R, et al. SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic. Ann Clin Microbiol Antimicrob 2020;19(1):40. DOI: 10.1186/s12941-020-00384-w
[2] Rodriguez-Morales AJ, Gallego V, Escalera-Antezana JP, et al. COVID-19 in Latin America: The implications of the first confirmed case in Brazil. Travel medicine and infectious disease 2020;35:101613. DOIi: 10.1016/j.tmaid.2020.101613
[3] Mangla S, Zohra Makkia FT, Pathak AK, et al. COVID-19 Vaccine Hesitancy and Emerging Variants: Evidence from Six Countries. Behavioral sciences (Basel, Switzerland) 2021;11. DOI: 10.3390/bs11110148
[4] Rabaan AA, Al-Ahmed SH, Sah R, et al. Recent advances in vaccine and immunotherapy for COVID-19. Hum Vaccin Immunother 2020;16:3011-22. DOI: 10.1080/21645515.2020.1825896
[5] Schlagenhauf P, Patel D, Rodriguez-Morales AJ, Gautret P, Grobusch MP, Leder K. Variants, vaccines and vaccination passports: Challenges and chances for travel medicine in 2021. Travel Med Infect Dis 2021;40:101996. DOI: 10.1016/j.tmaid.2021.101996
[6] Gomez-Marin JE. Autonomía farmacéutica y biotecnológica frente a emergencias sanitarias. Infectio 2020;24:199-200. DOI: 10.22354/in.v24i4.875
[7] Gomez Marín JE, Castaño Osorio JC, Patarroyo MA, et al. Una hoja de ruta para la Vacuna COVID 19 en Colombia, un reto posible. Infectio 2021;25:7-10. DOI: 10.22354/in.v25i1.901
[8] León-Figueroa DA, Bonilla-Aldana DK, Pachar M, et al. The never-ending global emergence of viral zoonoses after COVID-19? The rising concern of monkeypox in Europe, North America and beyond. Travel medicine and infectious disease 2022;49:102362. DOI: 10.1016/j.tmaid.2022.102362
[9] Farahat RA, Abdelaal A, Shah J, et al. Monkeypox outbreaks during COVID-19 pandemic: are we looking at an independent phenomenon or an overlapping pandemic? Ann Clin Microbiol Antimicrob 2022;21:26. DOI: 10.1186/s12941-022-00518-2
[10] Sah R, Abdelaal A, Asija A, et al. Monkeypox Virus Containment: The Application of Ring Vaccination and Possible Challenges. J Travel Med 2022. DOI: 10.1093/jtm/taac085
[11] Ortiz-Martínez Y, Zambrano-Sanchez G, Rodríguez-Morales AJ. Monkeypox and HIV/AIDS: When the outbreak faces the epidemic. Int J STD AIDS. 2022:9564624221114191. DOI: 10.1177/09564624221114191
[12] Rodríguez-Morales AJ, Cardona-Ospina JA, Collins MH. Emerging and Reemerging Vector-borne and Zoonotic Diseases. Front Med (Lausanne). 2021;8:714630. DOI: 10.3389/fmed.2021.714630
[13] Rodríguez-Morales AJ, Paniz-Mondolfi AE, Faccini-Martínez ÁA, Henao-Martínez AF, Ruiz-Saenz J, Martinez-Gutierrez M, Alvarado-Arnez LE, Gomez-Marin JE, Bueno-Marí R, Carrero Y, Villamil-Gomez WE, Bonilla-Aldana DK, Haque U, Ramirez JD, Navarro JC, Lloveras S, Arteaga-Livias K, Casalone C, Maguiña JL, Escobedo AA, Hidalgo M, Bandeira AC, Mattar S, Cardona-Ospina JA, Suárez JA. The Constant Threat of Zoonotic and Vector-Borne Emerging Tropical Diseases: Living on the Edge. Front Trop Dis. 2021;2:676905. DOI: 10.3389/fitd.2021.676905
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2022 Hechos Microbiológicos
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
